Global Epilepsy Monitoring Devices Market - 2025 -2033
Epilepsy Monitoring Devices Market Size and Trends
The global epilepsy monitoring devices market reached US$ 570.40 million in 2023, with a rise to US$ 604.08 million in 2024, and is expected to reach US$ 1,061.29 million by 2033, growing at a CAGR of 7.3% during the forecast period 2025–2033.
The growing prevalence of epilepsy and the rising need for continuous, accurate monitoring are driving the rapid adoption of epilepsy monitoring devices, enabling earlier diagnosis, better seizure management, and improved patient outcomes. By providing real-time data, enhancing diagnostic precision, and supporting remote monitoring, these devices are transforming clinical workflows and reducing the burden on specialized epilepsy centers. With advancements in wearable technology, AI integration, and cloud connectivity, epilepsy monitoring devices are becoming an essential component of modern neurological care, supporting personalized treatment strategies and broader healthcare initiatives focused on digital health and patient-centric management.
Key Market highlights
Driver: Rising epilepsy prevalence & diagnosis rates
As epilepsy’s global burden continues to grow, so does the need for accurate diagnosis and continuous monitoring. For instance, according to the World Health Organization, Epilepsy is a chronic, non-communicable brain disorder that can affect individuals of all ages. Globally, it impacts around 50 million people, making it one of the most widespread neurological conditions. Nearly 80% of those with epilepsy reside in low- and middle-income countries, where access to care remains limited. Importantly, studies suggest that up to 70% of patients could achieve a seizure-free life with accurate diagnosis and appropriate treatment.
These rising numbers mean a larger population requires diagnosis (EEG, imaging) and ongoing monitoring (ambulatory EEGs, seizure detection devices, implantable) to manage seizures, tailor treatment, and reduce risks. As awareness improves and more people are diagnosed, demand for advanced monitoring devices and related services increases sharply.
Restraint: Regulatory pathways & clinical validation requirements
Regulatory pathways and clinical validation requirements can significantly hamper the growth of the Epilepsy Monitoring Devices Market because these devices deal directly with neurological health, where accuracy, safety, and reliability are paramount. To secure approvals from agencies like the U.S. FDA or European CE, companies must conduct extensive clinical trials to demonstrate not only device efficacy but also long-term safety, data accuracy, and low false-positive/false-negative rates in seizure detection. This process is time-consuming and costly, often requiring multicenter trials and large patient cohorts.
Segmentation Analysis
The global epilepsy monitoring devices market is segmented by product type,end-user, and region.
Product Type:
The conventional devices segment is estimated to have 52.7% of the epilepsy monitoring devices market share.
Conventional devices such as video-EEG monitoring systems, in-hospital EEG units, and ambulatory EEGs remain the dominant segment in the epilepsy monitoring devices market. This dominance is primarily due to their long-standing clinical acceptance, proven diagnostic accuracy, and established reimbursement pathways in many regions. Hospitals and epilepsy monitoring units (EMUs) continue to rely on these systems as the gold standard for precise seizure detection, classification, and surgical evaluation. Their ability to provide synchronized video and EEG data offers a comprehensive picture of seizure activity, which is essential for accurate diagnosis and pre-surgical planning.
Moreover, clinicians are more comfortable with conventional devices since they have decades of validation, making them the first choice in both developed and emerging healthcare systems. Despite the higher costs and infrastructure requirements, the strong reliability, regulatory approvals, and established clinical workflows of conventional EEG monitoring ensure their continued dominance in the market.
The wearable devices segment is estimated to have 47.3% of the epilepsy monitoring devices market share.
Wearable epilepsy monitoring devices are the fastest-growing segment, propelled by technological advances, patient convenience, and the shift toward remote healthcare. Wearables such as wristbands, headbands, smartwatches, and implantable neurostimulator devices are gaining momentum because they allow continuous, real-time monitoring outside hospital settings, reducing the need for costly and inconvenient inpatient admissions. Their integration with AI algorithms, cloud-based platforms, and telemedicine enables early seizure detection, predictive analytics, and better treatment personalization. The COVID-19 pandemic further accelerated the adoption of remote and home-based monitoring, pushing healthcare providers and payers to consider wearables as cost-effective alternatives.
Additionally, rising epilepsy prevalence, growing acceptance of digital health, and increasing investment from medtech startups are fueling rapid innovation in this segment. As regulatory approvals catch up and reimbursement frameworks expand, wearables are expected to capture a significant share in the near future, transforming epilepsy care from hospital-centric monitoring to a more patient-centered, continuous, and proactive approach.
Geographical Analysis
The North America epilepsy monitoring devices market was valued at 38.2%market share in 2024
North America holds a dominant position in the epilepsy monitoring devices market owing to a combination of advanced healthcare infrastructure, high awareness levels, favorable reimbursement policies, and strong presence of leading device manufacturers. The region has one of the highest diagnosis and treatment rates for epilepsy, supported by specialized epilepsy monitoring units (EMUs) and widespread adoption of conventional EEG and video-EEG systems.
Moreover, North America is at the forefront of technological innovation, with major medtech companies and startups actively developing AI-enabled wearable devices, implantable neurostimulator systems, and cloud-connected platforms. For instance, in March 2025, EpiWatch, a spinout from Johns Hopkins Medicine, has obtained FDA 510(k) premarket clearance for its seizure detection platform powered by the Apple Watch. The solution is designed to continuously track and detect tonic-conic (grand mal) seizures, a severe form of epilepsy characterized by full-body convulsions and loss of consciousness.
Robust R&D investments, clinical trials led by academic medical centers, and faster regulatory approvals from the FDA compared to other regions also drive early adoption of next-generation monitoring solutions. The rising prevalence of epilepsy, with the CDC estimating around 3.4 million people living with epilepsy in the United States alone, continues to fuel the need for accurate, continuous monitoring. Together, these factors make North America the largest and most influential market for epilepsy monitoring devices globally.
The Europe Epilepsy Monitoring Devices market was valued at 21.7% market share in 2024
Europe represents a significant market for epilepsy monitoring devices, ranking just behind North America, supported by its strong healthcare infrastructure, well-defined regulatory frameworks, and widespread adoption of conventional EEG and video-EEG systems. Rising epilepsy prevalence, estimated at around 4–7 cases per 1,000 people, along with growing awareness and government investment in neurological care, are driving demand for advanced monitoring solutions.
The region is also seeing rapid uptake of wearable and ambulatory devices, as patients and clinicians increasingly prefer non-invasive, home-based monitoring integrated with telemedicine platforms. Countries such as Germany, the UK, France, and Spain lead adoption due to robust reimbursement structures and specialized epilepsy centers, while Eastern and Southern Europe are gradually catching up as healthcare modernization advances.
Europe’s commitment to digital health innovation, research funding, and the shift toward patient-centric care positions it as a key growth region for epilepsy monitoring devices in the coming years.
The Asia-Pacific Epilepsy Monitoring Devices market was valued at 18.6% market share in 2024
Asia-Pacific is projected to be the fastest-growing region in the epilepsy monitoring devices market, driven by a combination of rising epilepsy prevalence, increasing awareness. The region has a large patient pool, with studies estimating epilepsy prevalence ranging between 3–10 cases per 1,000 population in countries like India and China, yet underdiagnoses remains high, creating strong growth potential as access to care expands.
Governments and healthcare providers are investing in digital health and telemedicine initiatives, which complement the rising adoption of wearable and ambulatory monitoring devices, especially in rural and underserved areas. Growing collaborations between global medtech leaders and local players, alongside supportive regulatory reforms in markets such as Japan, South Korea, and Australia, are accelerating the introduction of advanced technologies like AI-enabled seizure detection and remote patient monitoring platforms. Additionally, the increasing affordability of mobile-based EEG devices and the adoption of cloud solutions are making monitoring more accessible. These factors, coupled with expanding insurance coverage and strong private-sector investment in healthcare, position Asia-Pacific as the fastest-growing market for epilepsy monitoring devices over the coming years.
Competitive Landscape
The major players in the epilepsy monitoring devices market include NIHON KOHDEN CORPORATION, Empatica Inc., Compumedics Limited, Natus, Cadwell Industries Inc., Ceribell, Inc., among others.
NIHON KOHDEN CORPORATION:
NIHON KOHDEN CORPORATION is a key player in the epilepsy monitoring devices market, offering advanced neurodiagnostic solutions such as the Neurofax EEG Systems and the EEG-1200 Neurofax System for long-term video-EEG monitoring in epilepsy centers. The company also provides wireless and portable EEG devices for ambulatory care and the Polysmith software platform for data analysis and seizure detection. With its strong focus on innovation and clinical reliability, Nihon Kohden continues to support accurate diagnosis and effective management of epilepsy worldwide.
Key Developments:
The global epilepsy monitoring devices market reached US$ 570.40 million in 2023, with a rise to US$ 604.08 million in 2024, and is expected to reach US$ 1,061.29 million by 2033, growing at a CAGR of 7.3% during the forecast period 2025–2033.
The growing prevalence of epilepsy and the rising need for continuous, accurate monitoring are driving the rapid adoption of epilepsy monitoring devices, enabling earlier diagnosis, better seizure management, and improved patient outcomes. By providing real-time data, enhancing diagnostic precision, and supporting remote monitoring, these devices are transforming clinical workflows and reducing the burden on specialized epilepsy centers. With advancements in wearable technology, AI integration, and cloud connectivity, epilepsy monitoring devices are becoming an essential component of modern neurological care, supporting personalized treatment strategies and broader healthcare initiatives focused on digital health and patient-centric management.
Key Market highlights
- North America dominates the market with a 38.2% revenue share, supported by advanced healthcare infrastructure, high epilepsy diagnosis rates, established reimbursement policies, and the strong presence of leading medical device manufacturers.
- Asia-Pacific is emerging as the fastest-growing region with an 18.6% share, driven by a large patient pool, expanding healthcare systems, rising awareness of epilepsy, and increasing adoption of wearable and ambulatory monitoring devices in countries such as China and India.
- The conventional devices segment leads the market with a 52.7% share, reflecting their clinical reliability, proven diagnostic accuracy, and continued preference among hospitals and epilepsy monitoring units (EMUs) as the gold standard for seizure evaluation and management.
- 2024 Market Size: US$604.08Million
- 2033 Projected Market Size: US$1,061.29 Million
- CAGR (2025–2033): 7.3%
- North America: Largest market in 2024
- Asia Pacific: Fastest-growing market
Driver: Rising epilepsy prevalence & diagnosis rates
As epilepsy’s global burden continues to grow, so does the need for accurate diagnosis and continuous monitoring. For instance, according to the World Health Organization, Epilepsy is a chronic, non-communicable brain disorder that can affect individuals of all ages. Globally, it impacts around 50 million people, making it one of the most widespread neurological conditions. Nearly 80% of those with epilepsy reside in low- and middle-income countries, where access to care remains limited. Importantly, studies suggest that up to 70% of patients could achieve a seizure-free life with accurate diagnosis and appropriate treatment.
These rising numbers mean a larger population requires diagnosis (EEG, imaging) and ongoing monitoring (ambulatory EEGs, seizure detection devices, implantable) to manage seizures, tailor treatment, and reduce risks. As awareness improves and more people are diagnosed, demand for advanced monitoring devices and related services increases sharply.
Restraint: Regulatory pathways & clinical validation requirements
Regulatory pathways and clinical validation requirements can significantly hamper the growth of the Epilepsy Monitoring Devices Market because these devices deal directly with neurological health, where accuracy, safety, and reliability are paramount. To secure approvals from agencies like the U.S. FDA or European CE, companies must conduct extensive clinical trials to demonstrate not only device efficacy but also long-term safety, data accuracy, and low false-positive/false-negative rates in seizure detection. This process is time-consuming and costly, often requiring multicenter trials and large patient cohorts.
Segmentation Analysis
The global epilepsy monitoring devices market is segmented by product type,end-user, and region.
Product Type:
The conventional devices segment is estimated to have 52.7% of the epilepsy monitoring devices market share.
Conventional devices such as video-EEG monitoring systems, in-hospital EEG units, and ambulatory EEGs remain the dominant segment in the epilepsy monitoring devices market. This dominance is primarily due to their long-standing clinical acceptance, proven diagnostic accuracy, and established reimbursement pathways in many regions. Hospitals and epilepsy monitoring units (EMUs) continue to rely on these systems as the gold standard for precise seizure detection, classification, and surgical evaluation. Their ability to provide synchronized video and EEG data offers a comprehensive picture of seizure activity, which is essential for accurate diagnosis and pre-surgical planning.
Moreover, clinicians are more comfortable with conventional devices since they have decades of validation, making them the first choice in both developed and emerging healthcare systems. Despite the higher costs and infrastructure requirements, the strong reliability, regulatory approvals, and established clinical workflows of conventional EEG monitoring ensure their continued dominance in the market.
The wearable devices segment is estimated to have 47.3% of the epilepsy monitoring devices market share.
Wearable epilepsy monitoring devices are the fastest-growing segment, propelled by technological advances, patient convenience, and the shift toward remote healthcare. Wearables such as wristbands, headbands, smartwatches, and implantable neurostimulator devices are gaining momentum because they allow continuous, real-time monitoring outside hospital settings, reducing the need for costly and inconvenient inpatient admissions. Their integration with AI algorithms, cloud-based platforms, and telemedicine enables early seizure detection, predictive analytics, and better treatment personalization. The COVID-19 pandemic further accelerated the adoption of remote and home-based monitoring, pushing healthcare providers and payers to consider wearables as cost-effective alternatives.
Additionally, rising epilepsy prevalence, growing acceptance of digital health, and increasing investment from medtech startups are fueling rapid innovation in this segment. As regulatory approvals catch up and reimbursement frameworks expand, wearables are expected to capture a significant share in the near future, transforming epilepsy care from hospital-centric monitoring to a more patient-centered, continuous, and proactive approach.
Geographical Analysis
The North America epilepsy monitoring devices market was valued at 38.2%market share in 2024
North America holds a dominant position in the epilepsy monitoring devices market owing to a combination of advanced healthcare infrastructure, high awareness levels, favorable reimbursement policies, and strong presence of leading device manufacturers. The region has one of the highest diagnosis and treatment rates for epilepsy, supported by specialized epilepsy monitoring units (EMUs) and widespread adoption of conventional EEG and video-EEG systems.
Moreover, North America is at the forefront of technological innovation, with major medtech companies and startups actively developing AI-enabled wearable devices, implantable neurostimulator systems, and cloud-connected platforms. For instance, in March 2025, EpiWatch, a spinout from Johns Hopkins Medicine, has obtained FDA 510(k) premarket clearance for its seizure detection platform powered by the Apple Watch. The solution is designed to continuously track and detect tonic-conic (grand mal) seizures, a severe form of epilepsy characterized by full-body convulsions and loss of consciousness.
Robust R&D investments, clinical trials led by academic medical centers, and faster regulatory approvals from the FDA compared to other regions also drive early adoption of next-generation monitoring solutions. The rising prevalence of epilepsy, with the CDC estimating around 3.4 million people living with epilepsy in the United States alone, continues to fuel the need for accurate, continuous monitoring. Together, these factors make North America the largest and most influential market for epilepsy monitoring devices globally.
The Europe Epilepsy Monitoring Devices market was valued at 21.7% market share in 2024
Europe represents a significant market for epilepsy monitoring devices, ranking just behind North America, supported by its strong healthcare infrastructure, well-defined regulatory frameworks, and widespread adoption of conventional EEG and video-EEG systems. Rising epilepsy prevalence, estimated at around 4–7 cases per 1,000 people, along with growing awareness and government investment in neurological care, are driving demand for advanced monitoring solutions.
The region is also seeing rapid uptake of wearable and ambulatory devices, as patients and clinicians increasingly prefer non-invasive, home-based monitoring integrated with telemedicine platforms. Countries such as Germany, the UK, France, and Spain lead adoption due to robust reimbursement structures and specialized epilepsy centers, while Eastern and Southern Europe are gradually catching up as healthcare modernization advances.
Europe’s commitment to digital health innovation, research funding, and the shift toward patient-centric care positions it as a key growth region for epilepsy monitoring devices in the coming years.
The Asia-Pacific Epilepsy Monitoring Devices market was valued at 18.6% market share in 2024
Asia-Pacific is projected to be the fastest-growing region in the epilepsy monitoring devices market, driven by a combination of rising epilepsy prevalence, increasing awareness. The region has a large patient pool, with studies estimating epilepsy prevalence ranging between 3–10 cases per 1,000 population in countries like India and China, yet underdiagnoses remains high, creating strong growth potential as access to care expands.
Governments and healthcare providers are investing in digital health and telemedicine initiatives, which complement the rising adoption of wearable and ambulatory monitoring devices, especially in rural and underserved areas. Growing collaborations between global medtech leaders and local players, alongside supportive regulatory reforms in markets such as Japan, South Korea, and Australia, are accelerating the introduction of advanced technologies like AI-enabled seizure detection and remote patient monitoring platforms. Additionally, the increasing affordability of mobile-based EEG devices and the adoption of cloud solutions are making monitoring more accessible. These factors, coupled with expanding insurance coverage and strong private-sector investment in healthcare, position Asia-Pacific as the fastest-growing market for epilepsy monitoring devices over the coming years.
Competitive Landscape
The major players in the epilepsy monitoring devices market include NIHON KOHDEN CORPORATION, Empatica Inc., Compumedics Limited, Natus, Cadwell Industries Inc., Ceribell, Inc., among others.
NIHON KOHDEN CORPORATION:
NIHON KOHDEN CORPORATION is a key player in the epilepsy monitoring devices market, offering advanced neurodiagnostic solutions such as the Neurofax EEG Systems and the EEG-1200 Neurofax System for long-term video-EEG monitoring in epilepsy centers. The company also provides wireless and portable EEG devices for ambulatory care and the Polysmith software platform for data analysis and seizure detection. With its strong focus on innovation and clinical reliability, Nihon Kohden continues to support accurate diagnosis and effective management of epilepsy worldwide.
Key Developments:
- In May 2025, Empatica proudly announces that EpiMonitor, its groundbreaking epilepsy monitoring solution, has received CE certification under the EU Medical Device Regulation (MDR 2017/745) and is now available for use across Europe.
- In February 2024, Empatica introduced EpiMonitor, an epilepsy monitoring system designed for both adults and children aged six years and older. Cleared by the U.S. Food and Drug Administration (FDA), EpiMonitor is an advanced wearable device engineered to accurately detect generalized tonic-clonic seizures.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by End-User
2.5. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Epilepsy Prevalence & Diagnosis Rates
3.1.1.2. Shift from Inpatient EMUs to Ambulatory & Home Monitoring
3.1.2. Restraints
3.1.2.1. Regulatory Pathways & Clinical Validation Requirements
3.1.2.2. Data Privacy, Security & Interoperability Concerns
3.1.3. Opportunity
3.1.3.1. AI-driven Seizure Forecasting & Personalized Care
3.1.3.2. Partnerships with Payers, Hospitals & Pharma
3.1.4. Impact Analysis
4. GLOBAL EPILEPSY MONITORING DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established products& Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Wearable Devices*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Conventional Devices
6. GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY END-USER
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
6.1.2. Market Attractiveness Index, By End-User
6.2. Hospitals*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Ambulatory Surgical Center
6.4. Home Care Settings
6.5. Others
7. REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
7.1.2. Market Attractiveness Index, By Region
7.2. North America
7.2.1. Introduction
7.2.2. Key Region-Specific Dynamics
7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.2.5.1. U.S.
7.2.5.2. Canada
7.2.5.3. Mexico
7.3. Europe
7.3.1. Introduction
7.3.2. Key Region-Specific Dynamics
7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.3.5.1. Germany
7.3.5.2. U.K.
7.3.5.3. France
7.3.5.4. Spain
7.3.5.5. Italy
7.3.5.6. Rest of Europe
7.4. South America
7.4.1. Introduction
7.4.2. Key Region-Specific Dynamics
7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.4.5.1. Brazil
7.4.5.2. Argentina
7.4.5.3. Rest of South America
7.5. Asia-Pacific
7.5.1. Introduction
7.5.2. Key Region-Specific Dynamics
7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.5.5.1. China
7.5.5.2. India
7.5.5.3. Japan
7.5.5.4. South Korea
7.5.5.5. Rest of Asia-Pacific
7.6. Middle East and Africa
7.6.1. Introduction
7.6.2. Key Region-Specific Dynamics
7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
8.1. Competitive Overview and Key Market Players
8.2. Market Share Analysis and Positioning Matrix
8.3. Strategic Partnerships, Mergers & Acquisitions
8.4. Key Developments in Product Portfolios and Innovations
8.5. Company Benchmarking
9. COMPANY PROFILES
9.1. NIHON KOHDEN CORPORATION*
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.2.1. Product Description
9.1.2.2. Product Key Performance Indicators (KPIs)
9.1.2.3. Historic and Forecasted Product Sales
9.1.2.4. Product Sales Volume
9.1.3. Financial Overview
9.1.3.1. Company Revenue
9.1.3.2. Geographical Revenue Shares
9.1.3.3. Revenue Forecasts
9.1.4. Key Developments
9.1.4.1. Mergers & Acquisitions
9.1.4.2. Key Product Development Activities
9.1.4.3. Regulatory Approvals, etc.
9.1.5. SWOT Analysis
9.2. Empatica Inc.
9.3. Compumedics Limited
9.4. Natus
9.5. Cadwell Industries Inc.
9.6. Ceribell, Inc. (LIST NOT EXHAUSTIVE)
10. ASSUMPTIONS AND RESEARCH METHODOLOGY
10.1. Data Collection Methods
10.2. Data Triangulation
10.3. Forecasting Techniques
10.4. Data Verification and Validation
11. APPENDIX
11.1. About Us and Services
11.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by End-User
2.5. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Epilepsy Prevalence & Diagnosis Rates
3.1.1.2. Shift from Inpatient EMUs to Ambulatory & Home Monitoring
3.1.2. Restraints
3.1.2.1. Regulatory Pathways & Clinical Validation Requirements
3.1.2.2. Data Privacy, Security & Interoperability Concerns
3.1.3. Opportunity
3.1.3.1. AI-driven Seizure Forecasting & Personalized Care
3.1.3.2. Partnerships with Payers, Hospitals & Pharma
3.1.4. Impact Analysis
4. GLOBAL EPILEPSY MONITORING DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established products& Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Wearable Devices*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Conventional Devices
6. GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY END-USER
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
6.1.2. Market Attractiveness Index, By End-User
6.2. Hospitals*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Ambulatory Surgical Center
6.4. Home Care Settings
6.5. Others
7. REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
7.1.2. Market Attractiveness Index, By Region
7.2. North America
7.2.1. Introduction
7.2.2. Key Region-Specific Dynamics
7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.2.5.1. U.S.
7.2.5.2. Canada
7.2.5.3. Mexico
7.3. Europe
7.3.1. Introduction
7.3.2. Key Region-Specific Dynamics
7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.3.5.1. Germany
7.3.5.2. U.K.
7.3.5.3. France
7.3.5.4. Spain
7.3.5.5. Italy
7.3.5.6. Rest of Europe
7.4. South America
7.4.1. Introduction
7.4.2. Key Region-Specific Dynamics
7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.4.5.1. Brazil
7.4.5.2. Argentina
7.4.5.3. Rest of South America
7.5. Asia-Pacific
7.5.1. Introduction
7.5.2. Key Region-Specific Dynamics
7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.5.5.1. China
7.5.5.2. India
7.5.5.3. Japan
7.5.5.4. South Korea
7.5.5.5. Rest of Asia-Pacific
7.6. Middle East and Africa
7.6.1. Introduction
7.6.2. Key Region-Specific Dynamics
7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
8.1. Competitive Overview and Key Market Players
8.2. Market Share Analysis and Positioning Matrix
8.3. Strategic Partnerships, Mergers & Acquisitions
8.4. Key Developments in Product Portfolios and Innovations
8.5. Company Benchmarking
9. COMPANY PROFILES
9.1. NIHON KOHDEN CORPORATION*
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.2.1. Product Description
9.1.2.2. Product Key Performance Indicators (KPIs)
9.1.2.3. Historic and Forecasted Product Sales
9.1.2.4. Product Sales Volume
9.1.3. Financial Overview
9.1.3.1. Company Revenue
9.1.3.2. Geographical Revenue Shares
9.1.3.3. Revenue Forecasts
9.1.4. Key Developments
9.1.4.1. Mergers & Acquisitions
9.1.4.2. Key Product Development Activities
9.1.4.3. Regulatory Approvals, etc.
9.1.5. SWOT Analysis
9.2. Empatica Inc.
9.3. Compumedics Limited
9.4. Natus
9.5. Cadwell Industries Inc.
9.6. Ceribell, Inc. (LIST NOT EXHAUSTIVE)
10. ASSUMPTIONS AND RESEARCH METHODOLOGY
10.1. Data Collection Methods
10.2. Data Triangulation
10.3. Forecasting Techniques
10.4. Data Verification and Validation
11. APPENDIX
11.1. About Us and Services
11.2. Contact Us
LIST OF TABLES
Table 1 Global Epilepsy Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 2 Global Epilepsy Monitoring Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)
Table 3 Global Epilepsy Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 4 Global Epilepsy Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 5 Global Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 6 Global Epilepsy Monitoring Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)
Table 7 Global Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 8 Global Epilepsy Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 9 Global Epilepsy Monitoring Devices Market Value, By Region, 2022-2033 (US$ Million)
Table 10 North America Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 11 North America Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 12 North America Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 13 Asia-Pacific Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 14 Asia-Pacific Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 15 Asia-Pacific Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 16 Europe Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 17 Europe Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 18 Europe Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 19 South America Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 20 South America Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 21 South America Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 22 Middle East and Africa Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 23 Middle East and Africa Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 24 Middle East and Africa Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 25 NIHON KOHDEN CORPORATION: Overview
Table 26 NIHON KOHDEN CORPORATION: Product Portfolio
Table 27 NIHON KOHDEN CORPORATION: Key Developments
Table 28 Empatica Inc.: Overview
Table 29 Empatica Inc.: Product Portfolio
Table 30 Empatica Inc.: Key Developments
Table 31 Compumedics Limited: Overview
Table 32 Compumedics Limited: Product Portfolio
Table 33 Compumedics Limited: Key Developments
Table 34 Natus: Overview
Table 35 Natus: Product Portfolio
Table 36 Natus: Key Developments
Table 37 Cadwell Industries Inc.: Overview
Table 38 Cadwell Industries Inc.: Product Portfolio
Table 39 Cadwell Industries Inc.: Key Developments
Table 40 Ceribell, Inc.: Overview
Table 41 Ceribell, Inc.: Product Portfolio
Table 42 Ceribell, Inc.: Key Developments
Table 1 Global Epilepsy Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 2 Global Epilepsy Monitoring Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)
Table 3 Global Epilepsy Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 4 Global Epilepsy Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 5 Global Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 6 Global Epilepsy Monitoring Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)
Table 7 Global Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 8 Global Epilepsy Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 9 Global Epilepsy Monitoring Devices Market Value, By Region, 2022-2033 (US$ Million)
Table 10 North America Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 11 North America Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 12 North America Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 13 Asia-Pacific Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 14 Asia-Pacific Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 15 Asia-Pacific Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 16 Europe Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 17 Europe Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 18 Europe Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 19 South America Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 20 South America Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 21 South America Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 22 Middle East and Africa Epilepsy Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 23 Middle East and Africa Epilepsy Monitoring Devices Market Value, By End-User, 2022-2033 (US$ Million)
Table 24 Middle East and Africa Epilepsy Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 25 NIHON KOHDEN CORPORATION: Overview
Table 26 NIHON KOHDEN CORPORATION: Product Portfolio
Table 27 NIHON KOHDEN CORPORATION: Key Developments
Table 28 Empatica Inc.: Overview
Table 29 Empatica Inc.: Product Portfolio
Table 30 Empatica Inc.: Key Developments
Table 31 Compumedics Limited: Overview
Table 32 Compumedics Limited: Product Portfolio
Table 33 Compumedics Limited: Key Developments
Table 34 Natus: Overview
Table 35 Natus: Product Portfolio
Table 36 Natus: Key Developments
Table 37 Cadwell Industries Inc.: Overview
Table 38 Cadwell Industries Inc.: Product Portfolio
Table 39 Cadwell Industries Inc.: Key Developments
Table 40 Ceribell, Inc.: Overview
Table 41 Ceribell, Inc.: Product Portfolio
Table 42 Ceribell, Inc.: Key Developments
LIST OF FIGURES
Figure 1 Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 2 Global Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 4 Global Epilepsy Monitoring Devices Market Share, By Region, 2024 & 2033 (%)
Figure 5 Global Epilepsy Monitoring Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 6 Conventional Devices Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 7 Wearable Devices Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 8 Global Epilepsy Monitoring Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 9 Hospitals End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 10 Ambulatory Surgical Center End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 11 Home Care Settings End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 12 Others End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 13 Global Epilepsy Monitoring Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 14 North America Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 15 North America Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 16 North America Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 17 North America Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 18 Asia-Pacific Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 19 Asia-Pacific Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 20 Asia-Pacific Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 21 Asia-Pacific Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 22 Europe Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 23 Europe Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 24 Europe Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 25 Europe Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 26 South America Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 27 South America Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 28 South America Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 29 South America Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 30 Middle East and Africa Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 31 Middle East and Africa Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 32 Middle East and Africa Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 33 NIHON KOHDEN CORPORATION: Financials
Figure 34 Empatica Inc.: Financials
Figure 35 Compumedics Limited: Financials
Figure 36 Natus: Financials
Figure 37 Cadwell Industries Inc.: Financials
Figure 38 Ceribell, Inc.: Financials
Figure 1 Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 2 Global Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 4 Global Epilepsy Monitoring Devices Market Share, By Region, 2024 & 2033 (%)
Figure 5 Global Epilepsy Monitoring Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 6 Conventional Devices Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 7 Wearable Devices Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 8 Global Epilepsy Monitoring Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 9 Hospitals End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 10 Ambulatory Surgical Center End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 11 Home Care Settings End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 12 Others End-User in Global Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 13 Global Epilepsy Monitoring Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 14 North America Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 15 North America Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 16 North America Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 17 North America Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 18 Asia-Pacific Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 19 Asia-Pacific Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 20 Asia-Pacific Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 21 Asia-Pacific Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 22 Europe Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 23 Europe Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 24 Europe Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 25 Europe Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 26 South America Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 27 South America Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 28 South America Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 29 South America Epilepsy Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 30 Middle East and Africa Epilepsy Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 31 Middle East and Africa Epilepsy Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 32 Middle East and Africa Epilepsy Monitoring Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 33 NIHON KOHDEN CORPORATION: Financials
Figure 34 Empatica Inc.: Financials
Figure 35 Compumedics Limited: Financials
Figure 36 Natus: Financials
Figure 37 Cadwell Industries Inc.: Financials
Figure 38 Ceribell, Inc.: Financials
